These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [The use of decision making analysis for evaluating hepatitis B inoculation strategy].
    Author: Zhuang GH, Xu HW.
    Journal: Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):69-73. PubMed ID: 8354107.
    Abstract:
    Using quality adjusted life year (QALY) as an evaluation measure of cost-effectiveness for assessing hepatitis B inoculation strategy in China, through the decision tree model. The result showed that for hepatitis B inoculation, priority should be given to neonates and infants aged 0-3 years; and the age of vaccination subjects be extended to, adults older than 25 yrs. The result also indicated: that the net cost for each QALY gained due to vaccination was very high, so that the ultimate control of hepatitis B epidemic not only depended on the development of highly effective and inexpensive vaccine, but also on the improvement of economic level and sanitary status.
    [Abstract] [Full Text] [Related] [New Search]